Adverum Biotechnologies Presents at the Piper Sandler Annual Virtual Healthcare Conference

Adverum Biotechnologies, Inc.

Mon, Nov 23, 2020, 11:00 AM1 min read

In this article:

REDWOOD CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the company’s presentation at the Piper Sandler 32^nd Annual Virtual Healthcare Conference.

Adverum’s video webcast will be accessible on demand beginning today at 10:00 am ET under Events and Presentations in the Investors section of the company's website. This webcast will be available on the Adverum website for 30 days.

About Adverum Biotechnologies
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. Adverum is advancing the clinical development of its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of patients with wet age-related macular degeneration and diabetic macular edema. For more information, please visit www.adverum.com.

CONTACT: Investor and Media Inquiries: Myesha Lacy Adverum Biotechnologies, Inc. mlacy@adverum.com 1-650-649-1257

Don't buy the dip in stocks just yet as a wave of selling is about to bring the market to a bottom, according to one of the biggest bulls on Wall Street
The S&P 500 could bottom out in the next month, according to Fundstrat's head of research Tom Lee.
Business Insider•1h ago
Dow Jones Futures Tumble On Iran Explosions; Stock Market About To Break Power Trend
Futures fell on reports of Iran explosions: The market power trend is about to end. Netflix gave weak guidance.
Investor's Business Daily•4m ago
Trump Media stock jumps for second day as company goes to battle with short sellers
Trump Media is advising investors on ways to prevent their shares from being loaned for a short-interest position.
Yahoo Finance•9h ago
Netflix reports strong subscriber gains, but Q2 revenue forecast disappoints
Netflix reported first quarter earnings after the bell on Thursday. Here's what to know.
Yahoo Finance•6h ago
Billionaire Warren Buffett Recently Cut This Stock From Berkshire Hathaway's Portfolio. It Just Dropped 53% In 1 Day. Here's What Investors Need to Know.
The insurer was accused by a short-seller of "extensive" fraud.
Motley Fool•2d ago
The Most Active Stock Trader in Congress Is Buying Shares of This Magnificent Stock-Split Stock
Wall Street's most-prominent stock-split stock of 2024 has been purchased on three separate occasions by a lawmaker who completed over 4,200 trades last year.
Motley Fool•17h ago
Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending'
In the chaos of the 2008 recession, perhaps no bank stood more prepared than Jamie Dimon's J.P Morgan Chase & Co. (NYSE:JPM). In advance of the crisis, Jamie Dimon realized that "underwriting standards were deteriorating across the industry," with late payments on subprime loans rising. In late 2006, the bank led his firm to exit Wall Street's hot subprime business, starting with a frantic call made to J.P. Morgan's vacationing Chief of Securitized Products where he said, "I really want you to w
Benzinga•11h ago
DJT Stock Jumps. The Truth Social Owner Is Showing Stockholders How to Block Short Sellers.
An FAQ on the Truth Social owner’s website gave stockholders multiple ways to avoid their shares being lent to short sellers.
Barrons.com•5h ago
4 Members of Congress Generated Triple-Digit Returns in the Stock Market Last Year: These Are the 3 Stocks They Bought
These members of Congress delivered greater returns than Warren Buffett in 2023.
Motley Fool•16h ago
Ask an Advisor: ‘Should I Be Moving Stocks to Bonds?' I'm 65 and Have 82% of My 401(k) in Equities
In my 401(k) retirement plan, I’m 82% stocks. I’m 65 and still working. Should I be moving my stocks to bonds? -Bob While it's not a satisfying answer, the real answer is that "it depends." The decision of whether to shift your 401(k) to a more conservative asset allocation will depend primarily on your longer-term […] The post Ask an Advisor: ‘Should I Be Moving Stocks to Bonds?’ I’m 65 and Have 82% of My 401(k) in Equities appeared first on SmartReads by SmartAsset.
SmartAsset•11h ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Adverum Biotechnologies Presents at the Piper Sandler Annual Virtual Healthcare Conference

Recommended Stories

Don't buy the dip in stocks just yet as a wave of selling is about to bring the market to a bottom, according to one of the biggest bulls on Wall Street

Dow Jones Futures Tumble On Iran Explosions; Stock Market About To Break Power Trend

Trump Media stock jumps for second day as company goes to battle with short sellers

Netflix reports strong subscriber gains, but Q2 revenue forecast disappoints

Billionaire Warren Buffett Recently Cut This Stock From Berkshire Hathaway's Portfolio. It Just Dropped 53% In 1 Day. Here's What Investors Need to Know.

The Most Active Stock Trader in Congress Is Buying Shares of This Magnificent Stock-Split Stock

Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending'

DJT Stock Jumps. The Truth Social Owner Is Showing Stockholders How to Block Short Sellers.

4 Members of Congress Generated Triple-Digit Returns in the Stock Market Last Year: These Are the 3 Stocks They Bought

Ask an Advisor: ‘Should I Be Moving Stocks to Bonds?' I'm 65 and Have 82% of My 401(k) in Equities